Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart

  • Cinzia Perrino
    Department of Advanced Biomedical Sciences, Federico II University, Via Pansini 5, 80131 Naples, Italy;
  • Albert-Laszló Barabási
    Center for Complex Networks Research and Department of Physics, Northeastern University, Boston, MA, USA;
  • Gianluigi Condorelli
    Department of Cardiovascular Medicine, Humanitas Research Hospital and Humanitas University, Rozzano, Italy;
  • Sean Michael Davidson
    The Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, London, UK;
  • Leon De Windt
    Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, 6229 ER Maastricht, The Netherlands;
  • Stefanie Dimmeler
    Institute for Cardiovascular Regeneration, University Frankfurt, Frankfurt, Germany;
  • Felix Benedikt Engel
    Experimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany;
  • Derek John Hausenloy
    The Hatter Cardiovascular Institute, University College London, London, UK;
  • Joseph Addison Hill
    Departments of Medicine (Cardiology) and Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA;
  • Linda Wilhelmina Van Laake
    Division of Heart and Lungs, Hubrecht Institute, University Medical Center Utrecht, Utrecht, The Netherlands;
  • Sandrine Lecour
    Hatter Cardiovascular Research Institute, University of Cape Town, Cape Town, South Africa;
  • Jonathan Leor
    Neufeld Cardiac Research Institute, Tel-Aviv University, Tel-Aviv, Israel;
  • Rosalinda Madonna
    Center of Aging Sciences and Translational Medicine – CESI-MeT, “G. d’Annunzio” University, Chieti, Italy; Institute of Cardiology, Department of Neurosciences, Imaging, and Clinical Sciences, “G. d’Annunzio” University, Chieti, Italy;
  • Manuel Mayr
    King's British Heart Foundation Centre, King's College London, London, UK;
  • Fabrice Prunier
    Department of Cardiology, Institut MITOVASC, University of Angers, University Hospital of Angers, Angers, France;
  • Joost Petrus Geradus Sluijter
    Cardiology and UMC Utrecht Regenerative Medicine Center, University Medical Center Utrecht, Utrecht, The Netherlands;
  • Rainer Schulz
    Institute of Physiology, Justus Liebig University Giessen, Giessen, Germany;
  • Thomas Thum
    Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany;
  • Kirsti Ytrehus
    Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway;
  • Péter Ferdinandy
    Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary;

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ